US 11690829
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
granted A61KA61K31/343A61K31/4045
Quick answer
US patent 11690829 (Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder) held by OVID THERAPEUTICS INC. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/343, A61K31/4045, A61K31/437, A61P